I dialled into the conference call.
Timing has been announced in the report.
Day Lewis - No timing mentioned (despite below suggesting H2FY20)
Adheris - Q4FY20
Zuellig - Q1FY21 (this appears to only be MedExpress, Alpro and Klinify are not there)
HMS - Q2FY21
...... but all of these are so far behind initial targets by 3 to 6 months or more.
I'm a bit confused by the UK wording "MedAdvisor signed an agreement with UK-based Day Lewis Pharmacy Group to develop a solution".
Develop a solution? Isn't the solution PlusOne and the supporting app?
I recall the Adheris Health Program would provide revenue of $825k during the 9 month pilot. If the program went live last quarter, when are they expecting to receive payment?
Regarding range, they have specified what the target addressable market is in each region. I think I know where you're heading with the question - there's no quantifiable figure with each opportunity, just a very vague, large number.
![]()
Encouraging metric is the cash balance appears to mostly hold through each quarter, still over $12M.
- Forums
- ASX - By Stock
- Ann: MedAdvisor 2020 Annual Report & Appendix 4E
I dialled into the conference call. Timing has been announced in...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
|
|||||
Last
45.5¢ |
Change
0.010(2.25%) |
Mkt cap ! $250.8M |
Open | High | Low | Value | Volume |
44.5¢ | 45.5¢ | 44.5¢ | $683.4K | 1.508M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7000 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 34999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7000 | 0.450 |
3 | 35942 | 0.445 |
1 | 3409 | 0.440 |
2 | 15252 | 0.435 |
4 | 104839 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.455 | 34999 | 1 |
0.460 | 16000 | 1 |
0.465 | 10000 | 1 |
0.470 | 11104 | 1 |
0.475 | 21444 | 2 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online